VAERS Explorer
Back to explore

Report #2849095

Received Jul 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
KS
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (PRIORIX)GLAXOSMITHKLINE BIOLOGICALSUNK3ZE3E—

Symptoms (1)

Product preparation issue

Symptom narrative

Maladministration of the diluent only; Maladministration of the diluent only; This non-serious case was reported by a consumer via call center representative and described the occurrence of inappropriate preparation of medication in a 28-year-old female patient who received MMR (Priorix) (batch number 3ZE3E, expiry date 22-NOV-2028) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: Maladministration of the diluent only) and inappropriate dose of vaccine administered (Verbatim: Maladministration of the diluent only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-JUN-2025 The reporter reported that there was maladministration of a Priorix diluent before reconstituting, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. They request information about what to do. The Vaccine Administration Facility is the same as Primary Reporter